These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28838462)

  • 1. Drug-Eluting Balloons-A New Tool in the Treatment of Cardiac Allograft Vasculopathy: A Case Series.
    Skoric B; Bulum J; Cikes M; Jurin H; Lovric D; Ljubas-Macek J; Samardzic J; Pasalic M; Milicic D
    Transplant Proc; 2017 Sep; 49(7):1675-1677. PubMed ID: 28838462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous coronary artery revascularization procedures in pediatric heart transplant recipients: A large single center experience.
    Turner ME; Addonizio LJ; Richmond ME; Zuckerman WA; Vincent JA; Torres AJ; Collins MB
    Catheter Cardiovasc Interv; 2016 Nov; 88(5):797-803. PubMed ID: 27083510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case Report of Drug-Eluting Balloon as a New Treatment Option for Cardiac Allograft Vasculopathy.
    Gulin D; Galic E; Sikic J
    Prog Transplant; 2018 Jun; 28(2):189-190. PubMed ID: 29595082
    [No Abstract]   [Full Text] [Related]  

  • 4. Percutaneous coronary interventions in cardiac allograft vasculopathy: a single-center experience.
    Colombo P; Bruschi G; Sacco A; Oreglia J; De Marco F; Colombo T; Botta L; Macera F; Turazza F; Frigerio M; Martinelli L; Klugmann S
    Transplant Proc; 2010 May; 42(4):1286-90. PubMed ID: 20534283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robotic Coronary Artery Bypass Grafting for Transplant Vasculopathy.
    Torregrossa G; Bravo M; Mancini D; Puskas J
    Ann Thorac Surg; 2019 Aug; 108(2):e77-e79. PubMed ID: 30710522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous coronary intervention versus medical therapy for coronary allograft vasculopathy. One center's experience.
    Aranda JM; Pauly DF; Kerensky RA; Cleeton TS; Walker TC; Schofield RS; Leach D; Lin L; Monroe V; Calderon RE; Hill JA
    J Heart Lung Transplant; 2002 Aug; 21(8):860-6. PubMed ID: 12163085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of percutaneous coronary intervention with bare-metal and drug-eluting stents for cardiac allograft vasculopathy.
    Lee MS; Kobashigawa J; Tobis J
    JACC Cardiovasc Interv; 2008 Dec; 1(6):710-5. PubMed ID: 19463388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug eluting or bare metal stents in cardiac allograft vasculopathy: the role of oral sirolimus.
    Mieres J; Fernandez-Pereira C; Rodriguez-Granillo AM; Rodriguez AE
    Catheter Cardiovasc Interv; 2012 Feb; 79(3):496; author reply 497. PubMed ID: 21805610
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term clinical outcomes after percutaneous coronary intervention for unprotected left main coronary artery in heart transplant patients with cardiac allograft vasculopathy.
    Alam M; Shahzad SA; Akhtar A; Huang HD; Rogers PA; Ramanathan KB; Kleiman NS; Jneid H
    Int J Cardiol; 2012 Apr; 156(1):101-4. PubMed ID: 22265322
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug eluting versus bare metal stents in cardiac allograft vasculopathy: a systematic review of literature.
    Dasari TW; Hennebry TA; Hanna EB; Saucedo JF
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):962-9. PubMed ID: 21413135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and in hospital outcomes of heart transplant recipients with allograft vasculopathy undergoing percutaneous coronary intervention: Insights from the National Cardiovascular Data Registry.
    Dasari TW; Saucedo JF; Krim S; Alkhouli M; Fonarow GC; Alvarez R; Ibrahim H; Dai D; Wang TY; Costa M; Lindenfeld J; Messenger JC
    Am Heart J; 2015 Dec; 170(6):1086-91. PubMed ID: 26678629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in Heart Transplant Recipients With Transplant Coronary Arterial Vasculopathy.
    Kuroda K; Sunami H; Matsumoto Y; Nakajima S; Sato T; Seguchi O; Hata H; Yanase M; Fujita T; Kobayashi J; Fukushima N
    Transplant Proc; 2017; 49(1):130-134. PubMed ID: 28104120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volumetric intravascular ultrasound assessment of mechanisms and results of stent expansion in heart transplant patients.
    Sanidas EA; Maehara A; Mintz GS; Kubo T; Gupta A; Apfelbaum MA; Hakim D; Moses JW; Mancini DM; Rabbani LE
    Catheter Cardiovasc Interv; 2013 Feb; 81(3):429-35. PubMed ID: 22461357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of bare metal versus drug-eluting stents in allograft vasculopathy.
    Reddy PR; Gulati A; Steen L; Sinacore J; Leya F; Heroux A
    J Heart Lung Transplant; 2008 Nov; 27(11):1222-8. PubMed ID: 18971095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes after percutaneous coronary intervention of left main coronary artery for treatment of cardiac allograft vasculopathy after orthotopic heart transplantation.
    Lee MS; Yang T; Fearon WF; Ho M; Tarantini G; Xhaxho J; Gerosa G; Weston M; Ehdaie A; Rabbani L; Kirtane AJ
    Am J Cardiol; 2010 Oct; 106(8):1086-9. PubMed ID: 20920643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes after percutaneous coronary artery revascularization procedures for cardiac allograft vasculopathy in pediatric heart transplant recipients: A multi-institutional study.
    Jeewa A; Chin C; Pahl E; Atz AM; Carboni MP; Pruitt E; Naftel DC; Rodriguez R; Dipchand AI;
    J Heart Lung Transplant; 2015 Sep; 34(9):1163-8. PubMed ID: 25578627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous coronary intervention: balloons, stents and scaffolds.
    Colleran R; Kastrati A
    Clin Res Cardiol; 2018 Aug; 107(Suppl 2):55-63. PubMed ID: 30039189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing long-term outcomes between drug-eluting and bare-metal stents in the treatment of cardiac allograft vasculopathy.
    Nfor T; Ansaarie I; Gupta A; Bajwa T; Allaqaband S
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):543-9. PubMed ID: 19405161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Angina pectoris in patients who underwent stent implantations for severe atherosclerotic coronary lesions 16 years after heart transplantation].
    Yamada A; Ishii Y; Kakizawa Y; Ishige A; Ueno H; Omichi C; Tanaka T; Nagashima H; Kanmatsuse K; Endo M
    Kyobu Geka; 2007 Oct; 60(11):969-73. PubMed ID: 17926899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of in-stent restenosis in cardiac allograft vasculopathy following implantation of a sirolimus-eluting stent.
    Wessely R; Pache J; Schömig A
    Transpl Int; 2005 Sep; 18(9):1113-5. PubMed ID: 16101733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.